Does needle-type increase the diagnostic yield of malignancies in endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA)?-a prospective comparative study.
Lung cancer
endobronchial ultrasound (EBUS)
endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA)
endoscopy
minimally invasive techniques
Journal
Journal of thoracic disease
ISSN: 2072-1439
Titre abrégé: J Thorac Dis
Pays: China
ID NLM: 101533916
Informations de publication
Date de publication:
Apr 2022
Apr 2022
Historique:
received:
06
10
2021
accepted:
04
03
2022
entrez:
16
5
2022
pubmed:
17
5
2022
medline:
17
5
2022
Statut:
ppublish
Résumé
Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a commonly performed minimally invasive technique for diagnosing mediastinal pathologies. Currently, many needle types are being developed to improve the accuracy of the final diagnosis. Our study aimed to assess the possible advantages and disadvantages between the 22-gauge ProCore In this prospective study, we enrolled a group of 363 EBUS-TBNA patients. For each patient, we used either the ProCore By using EBUS-TBNA, a diagnosis was established in 306 patients (84.3%). The rates of the final diagnoses in ProCore Both types of needles demonstrated very high diagnostic efficiency for malignancy, and there was no significant advantage of the ProCore
Sections du résumé
Background
UNASSIGNED
Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a commonly performed minimally invasive technique for diagnosing mediastinal pathologies. Currently, many needle types are being developed to improve the accuracy of the final diagnosis. Our study aimed to assess the possible advantages and disadvantages between the 22-gauge ProCore
Methods
UNASSIGNED
In this prospective study, we enrolled a group of 363 EBUS-TBNA patients. For each patient, we used either the ProCore
Results
UNASSIGNED
By using EBUS-TBNA, a diagnosis was established in 306 patients (84.3%). The rates of the final diagnoses in ProCore
Conclusions
UNASSIGNED
Both types of needles demonstrated very high diagnostic efficiency for malignancy, and there was no significant advantage of the ProCore
Identifiants
pubmed: 35572913
doi: 10.21037/jtd-21-1594
pii: jtd-14-04-884
pmc: PMC9096298
doi:
Types de publication
Journal Article
Langues
eng
Pagination
884-891Informations de copyright
2022 Journal of Thoracic Disease. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-21-1594/coif). The authors have no conflicts of interest to declare.
Références
Med Devices (Auckl). 2016 Mar 29;9:467-73
pubmed: 27099535
J Bronchology Interv Pulmonol. 2011 Jul;18(3):239-46
pubmed: 23208567
Thorax. 1992 Jul;47(7):565-7
pubmed: 1412103
Lung Cancer. 2005 Dec;50(3):347-54
pubmed: 16171897
Am J Respir Crit Care Med. 1999 Aug;160(2):736-55
pubmed: 10430755
J Vis Surg. 2018 Feb 27;4:37
pubmed: 29552519
J Thorac Dis. 2019 Aug;11(8):3270-3275
pubmed: 31559029
J Cytol. 2017 Apr-Jun;34(2):73-77
pubmed: 28469313
Gastrointest Endosc Clin N Am. 2014 Jan;24(1):19-27
pubmed: 24215758
World J Gastroenterol. 2016 Oct 21;22(39):8820-8830
pubmed: 27818598
Korean J Intern Med. 2016 Nov;31(6):1073-1083
pubmed: 27586867
Respiration. 2013;85(6):486-92
pubmed: 23571718
Ir J Med Sci. 2019 Feb;188(1):85-88
pubmed: 29693234
Chest. 2013 Apr;143(4):1036-1043
pubmed: 23632441
Thorac Cancer. 2020 Mar;11(3):748-753
pubmed: 31989777
Surg Endosc. 2017 Jan;31(1):225-230
pubmed: 27194261
Respirology. 2011 Jan;16(1):90-4
pubmed: 20920141
Chest. 1999 Jun;115(6):1500-6
pubmed: 10378540
Respirology. 2014 Jul;19(5):735-9
pubmed: 24697875
Sci Rep. 2021 May 7;11(1):9789
pubmed: 33963234
Expert Rev Med Devices. 2021 Feb;18(2):211-216
pubmed: 33435733
Endoscopy. 2016 Apr;48(4):339-49
pubmed: 26561917
Chest. 2013 Apr;143(4):1044-1053
pubmed: 23117878
J Cancer Res Ther. 2011 Apr-Jun;7(2):148-51
pubmed: 21768701
Gastrointest Endosc. 2013 Jun;77(6):909-15
pubmed: 23433596
Lung Cancer. 2009 Jan;63(1):45-9
pubmed: 18514365
Expert Rev Respir Med. 2015 Feb;9(1):45-53
pubmed: 25496515
J Bronchology Interv Pulmonol. 2011 Oct;18(4):306-10
pubmed: 23208623